Links

Homepage

Stock List

Search by Ticker

News

Login

Johnson & Johnson (NYSE:JNJ)
Stock Analysis

JNJ148.6
▲ 0.71%1.05

Stock Analysis

The following stock analysis is based on 7.8 years of data (i.e. since Oct 31, 2012). All the stock history has been downloaded.

Stock Exchange

Johnson & Johnson trades on the NYSE exchange in USD dollars.

Sector

It is in the healthcare sector.

Current Status of Johnson & Johnson

It is currently trading at $148.6 ($147.55 the previous day).It pays a 2.62% dividend.

Financials

The next reporting date is in 65 days (2020 10 13).

CNN estimates profits for the upcoming quarter will be $1.96 per share ($20.1B). The current Canada / US exchange rate is 1.3382.



Over the past 12 months, $13095242 worth of shares have been purchased and $19048319 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 8.1% per year assuming steady exponential growth. The actual 5 year average is 6.4. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year138.99958620691.6- Below Average
2 year136.751453.3- Below Average
3 year132.400669456078.2+ Above Average
4 year122.3575102040814.5+ Above Average
5 year106.904339622644.4- Below Average
Johnson & Johnson is projected by analysts to get to $170.00 within the next 12 months (14.4%), but preticted targets range from as high as $182.00 (22.5%) and as low as $142(-4.4%).

Risk

The worst drop it has had in recent years is -42.7%. It has a few bumps shape to the stock curve, which means the stock generally continues on a consistent trend and does not have to be checked often, but can have some variation during periods of volitility.

Stock shape test

DAYS AG0PRICE
10149.61DROPPING
30143.62RISING
60147.3DROPPING
150142.03RISING
365128.87RISING
800119.4RISING
1200122.89DROPPING
1600107.5RISING
200099.62RISING


With an average increase of 8.1% year over year, if Johnson & Johnson is bought at the worst time, Stockmarketizer analysts estimate it will take 63.3 months before the stock will recover to the original purchase price. The P/E value is 26.14. The stock is under valued as the industry standard in the healthcare sector is a P/E of 86.26.

Tradingview BuySell Widget

Yahoo News Feed

Johnson and Johnson stock outperforms market on strong trading day

Fri, 07 Aug 2020 20:25:00 COMPANY CLOSE UPDATES Terrence Horan Shares of Johnson and Johnson JNJ inched 0.71% higher to $148.60 Friday, on what proved to be an all-around favorable trading session for the stock market, with the SandP 500 Index SPX rising 0.... Read Full Article

Yacktman Asset Managementand's Top 5 Sells of the 2nd Quarter

Thu, 06 Aug 2020 22:24:20 Texas-based firm cuts back on big-name companies as Nasdaq hits 11,000 for the first time Continue reading...... Read Full Article

Johnson and Johnson stock falls Thursday, underperforms market

Thu, 06 Aug 2020 20:25:00 COMPANY CLOSE UPDATES Terrence Horan Shares of Johnson and Johnson JNJ dropped 0.57% to $147.55 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the SandP 500 Index SPX rising 0.... Read Full Article

Dow Jones Rises On Jobless Claims; Two Leaderboard Stocks In Buy Zones

Thu, 06 Aug 2020 19:00:37 The Dow Jones Industrial Average rose slightly in todayand's stock market as better-than-expected weekly jobless claims were reported Thursday morning.... Read Full Article

Return On Capital Employed Overview: Johnson and Johnson

Thu, 06 Aug 2020 18:22:44 Looking at Q2, Johnson and Johnson (NYSE: JNJ) earned $3.99 billion, a 31.06% increase from the preceding quarter. Johnson and Johnsonand's sales decreased to $18.34 billion, a 11.38% change since Q1. In Q1, Johnson and Johnson earned $5.79 billion, and total sales reached $20.69 billion.What ...... Read Full Article

MediPharm Labs Appoints Former Janssen Exec To Board

Thu, 06 Aug 2020 18:17:10 MediPharm Labs Corp. (OTC: MEDIF) recently appointed Chris Halyk to its board of directors.Halyk is the former President of Janssen Inc. (Canada), which is part of Johnson and Johnson (NYSE: JNJ)and's Janssen Pharmaceutical Companies. he brings 35 years of ...... Read Full Article

Buy Moderna Stock as the COVID-19 Vaccine Race Heats Up, Says 5-Star Analyst

Thu, 06 Aug 2020 18:04:58 The race to be first to market with a COVID-19 vaccine is changing gears. As the companies developing vaccine/therapeutics move further down the development path, the commercial aspect is starting to take a more prominent part in the conversation....... Read Full Article

Dow Jones Leads As Apple Eyes New High; Stocks Mixed After Jobless Claims Data

Thu, 06 Aug 2020 16:31:08 Stocks sought direction midday after the jobless claims report as the Dow Jones Industrial Average edged higher but the SandP; 500 slipped.... Read Full Article

Trump says coronavirus vaccine possible before Nov. 3

Thu, 06 Aug 2020 13:53:18 ... Read Full Article

U.S. FDA approves GlaxoSmithKlineand's blood cancer drug

Thu, 06 Aug 2020 01:52:38 The U.S. Food and Drug Administration on Wednesday approved GlaxoSmithKline's experimental treatment for a common form of blood cancer. GSK's belantamab mafodotin, or BLENREP, was approved for treating adults with relapsed and refractory multiple myeloma who no longer respond ...... Read Full Article

PRESS DIGEST- Financial Times - Aug. 6

Thu, 06 Aug 2020 01:25:19 ... Read Full Article

Asian Stocks Down Over Mixed U.S. Economic Data and Stall in Stimulus Measures

Wed, 05 Aug 2020 23:08:42 By Gina Lee... Read Full Article

4 High-Quality SandP Stocks With High 6-Month Total Returns

Wed, 05 Aug 2020 23:00:01 Stocks with high strength and profitability that have gained more than 30% over the past 6 months Continue reading...... Read Full Article

‘Every country should be able to afford’ the coronavirus vaccine: doctor

Wed, 05 Aug 2020 21:00:03 As Johnson and Johnson announced its latest deal with the United States to allocate 100 million doses of its vaccine for $1 billion dollars, Moderna priced in its vaccine for $32 to $37 dollars per dose. Dr. Carlos del Rio, Professor of Medicine, Global ...... Read Full Article

Novavax Stock Spirals To Record High On Positive Coronavirus Vaccine Data

Wed, 05 Aug 2020 20:14:48 Novavax stock shot up to a record high Wednesday after the company announced some positive results from early-stage testing of a coronavirus vaccine that has $1.6 billion in U.S. funding.... Read Full Article

Dow Jones Rises After Disney Earnings Beat

Wed, 05 Aug 2020 19:19:39 The Dow Jones Industrial Average rose in todayand's stock market as better-than-expected earnings continue to pour in from companies.... Read Full Article

'We’ve never moved this fast on a vaccine’: Former CDC Adviser

Wed, 05 Aug 2020 18:46:29 Dr. Roger Klein, Former Adviser to the FDA and the CDC, joins Yahoo Finance’s Kristin Myers to discuss his thoughts on the coronavirus vaccine front, as both Johnson and Johnson and Moderna announce new developments in their negotiations and ...... Read Full Article

Market will 'not like it’ if stimulus talks stop and no consensus is met: Bob Doll

Wed, 05 Aug 2020 18:46:17 Chief Equity Strategist and Senior Portfolio Manager at Nuveen Bob Doll joins Yahoo Finance’s Kristin Myers to discuss his outlook on the markets as Democrats and the White House aim to reach a coronavirus stimulus deal.... Read Full Article

Dow Jones Up 700 Points This Week; Nasdaq Hits Another New High

Wed, 05 Aug 2020 17:35:31 The Dow Jones Industrial Average held near session highs as the stock market rallied on Disney earnings and coronavirus vaccine news.... Read Full Article
<